According to DelveInsight, the market size of Progressive Supranuclear Palsy in 7MM was found to be USD 10.54 Million in 2017 and is expected to increase during the study period (2017-2030).
In 2017, the total prevalent cases of Progressive Supranuclear Palsy were found to be 98,498 in seven major markets.
The key players in Progressive Supranuclear Palsy market include AlzProtect, UCB Biopharma, Asceneuron Therapeutics, TauRx Pharmaceuticals and others.
For more detailed information visit: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market